Company Filing History:
Years Active: 2023
Title: Yueli Fu: Innovator in Kinase Inhibitor Compounds
Introduction
Yueli Fu is a prominent inventor based in Fujian, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. His innovative work has led to the creation of valuable compounds that have potential therapeutic applications.
Latest Patents
Yueli Fu holds a patent for "Heteroaryl compounds as kinase inhibitor." This patent describes compounds of formula (I) that exhibit activity on a receptor protein tyrosine kinase. The patent details various components, including R, R, R, A, Q, Z, X, and W, as well as their solvates, hydrates, tautomers, or pharmaceutically acceptable salts.
Career Highlights
Fu is associated with Fujian Haixi Pharmaceuticals Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry has positioned him as a key player in the innovation of new therapeutic agents.
Collaborations
Yueli Fu collaborates with talented colleagues, including Yan Feng and Ruyong Wang. Their combined expertise enhances the research and development capabilities within their organization.
Conclusion
Yueli Fu's contributions to the field of kinase inhibitors exemplify the impact of innovative research in pharmaceuticals. His work not only advances scientific knowledge but also holds promise for future medical applications.